| Dr Lydia Inez Gilbert-mcclain, MD | |
|
8600 Old Georgetown Rd, Bethesda, MD 20814-1497 | |
| (301) 896-3100 | |
| Not Available |
| Full Name | Dr Lydia Inez Gilbert-mcclain |
|---|---|
| Gender | Female |
| Speciality | Critical Care (intensivists) |
| Experience | 38 Years |
| Location | 8600 Old Georgetown Rd, Bethesda, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861513301 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | D0051485 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Suburban Hospital | Bethesda, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Johns Hopkins Community Physicians | 8325943707 | 568 |
News Archive
One of the most important working parts of Stanford Hospital is practically invisible ― and its invention dates back more than 200 years.
"In a decisive victory for India's pharmaceutical industry, India's Supreme Court rejected Novartis' patent application for the cancer drug Glivec on Monday, ending a seven-year battle by the Swiss drug maker to get a patent in India on its powerful leukemia drug," Time reports (Mahr, 4/1).
A new form of chemotherapy that destroys new blood vessels that grow around tumors has produced excellent results in a phase II trial of patients with inoperable pancreatic cancer, researchers report at the 33rd Congress of the European Society for Medical Oncology (ESMO) in Stockholm.New drug substantially extends survival in pancreatic cancer
Researchers at Baylor College of Medicine, Texas Children's Hospital and Rice University have uncovered a gene mutation that may provide answers to unexplained female infertility. The study appears in Scientific Reports, a member of the Nature family of journals.
› Verified 9 days ago
| Entity Name | Johns Hopkins Community Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255359972 PECOS PAC ID: 8325943707 Enrollment ID: O20040130000162 |
News Archive
One of the most important working parts of Stanford Hospital is practically invisible ― and its invention dates back more than 200 years.
"In a decisive victory for India's pharmaceutical industry, India's Supreme Court rejected Novartis' patent application for the cancer drug Glivec on Monday, ending a seven-year battle by the Swiss drug maker to get a patent in India on its powerful leukemia drug," Time reports (Mahr, 4/1).
A new form of chemotherapy that destroys new blood vessels that grow around tumors has produced excellent results in a phase II trial of patients with inoperable pancreatic cancer, researchers report at the 33rd Congress of the European Society for Medical Oncology (ESMO) in Stockholm.New drug substantially extends survival in pancreatic cancer
Researchers at Baylor College of Medicine, Texas Children's Hospital and Rice University have uncovered a gene mutation that may provide answers to unexplained female infertility. The study appears in Scientific Reports, a member of the Nature family of journals.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lydia Inez Gilbert-mcclain, MD 8007 River Gate Ln, Bowie, MD 20715-3328 Ph: (301) 809-5517 | Dr Lydia Inez Gilbert-mcclain, MD 8600 Old Georgetown Rd, Bethesda, MD 20814-1497 Ph: (301) 896-3100 |
News Archive
One of the most important working parts of Stanford Hospital is practically invisible ― and its invention dates back more than 200 years.
"In a decisive victory for India's pharmaceutical industry, India's Supreme Court rejected Novartis' patent application for the cancer drug Glivec on Monday, ending a seven-year battle by the Swiss drug maker to get a patent in India on its powerful leukemia drug," Time reports (Mahr, 4/1).
A new form of chemotherapy that destroys new blood vessels that grow around tumors has produced excellent results in a phase II trial of patients with inoperable pancreatic cancer, researchers report at the 33rd Congress of the European Society for Medical Oncology (ESMO) in Stockholm.New drug substantially extends survival in pancreatic cancer
Researchers at Baylor College of Medicine, Texas Children's Hospital and Rice University have uncovered a gene mutation that may provide answers to unexplained female infertility. The study appears in Scientific Reports, a member of the Nature family of journals.
› Verified 9 days ago
Ardalan Enkeshafi, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 6410 Rockledge Dr Ste 304, Bethesda, MD 20817 Phone: 443-602-6207 | |
Dr. Tara Palmore, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 Center Dr, Msc 1888, Bethesda, MD 20892 Phone: 301-496-4000 | |
Dr. Cornelia Diana Cudrici, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 Center Drive Bld 10 Rm 6n216a, Bethesda, MD 20892 Phone: 301-443-5519 | |
Shanthi Murgesh Nadar, Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 8600 Old Georgetown Road, Bethesda, MD 20814 Phone: 301-896-3100 | |
Dr. Nicole Jeanine Gormley, M.D. Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 10 Center Dr, Bldg 10, Rm 2c145, Bethesda, MD 20892 Phone: 301-496-9320 | |
Dr. Harshkumar Patel, MBBS Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 10 Center Dr, Bethesda, MD 20892 Phone: 301-496-9320 Fax: 301-402-1213 | |
Dr. Tung N Dao, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 6410 Rockledge Dr, Ste 200, Bethesda, MD 20817 Phone: 301-897-5301 Fax: 301-564-4289 |